Related Experiment Video
Updated: Jun 1, 2026

05:49
Robust Generation of Hepatocyte-like Cells from Human Embryonic Stem Cell Populations
Published on: October 26, 2011
Functional human artificial chromosomes are generated and stably maintained in human embryonic stem cells.
Mohammad A Mandegar1, Daniela Moralli, Suhail Khoja
1Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK.
Human Molecular Genetics
|May 20, 2011
Summary
Researchers developed a new gene expression system using human artificial chromosomes (HAC) in human embryonic stem cells (hESc). This system enables stable, non-integrating gene expression in stem cells, paving the way for therapeutic applications.
Area of Science:
- Stem cell biology
- Genetics
- Molecular biology
Background:
- Human artificial chromosomes (HAC) are valuable tools for studying chromosome structure and gene function.
- Previous attempts to create HACs were limited to tumor-derived cell lines, hindering stem cell applications.
- Efficient transfer and stable maintenance of HACs in stem cells remained a challenge.
Purpose of the Study:
- To establish a novel, non-integrating gene expression system in human embryonic stem cells (hESc) using HACs.
- To demonstrate the stable maintenance and gene expression capability of HACs in hESc.
- To overcome limitations in applying HAC technology to pluripotent stem cells for therapeutic purposes.
Main Methods:
- Modification of the herpes simplex virus type 1 amplicon system for HAC DNA transfer.
- Introduction of HAC DNA into two hESc lines.
- Assessment of gene expression (GFP), HAC stability, integration, and pluripotency markers.
- Teratoma formation assays to evaluate stem cell differentiation potential.
Main Results:
- Successfully generated gene-expressing HACs in hESc at high frequency.
- HACs were stably maintained for at least 3 months without selection.
- No integration of HAC DNA into the host genome was observed in hESc, unlike in control fibrosarcoma cells.
- hESc retained pluripotency, differentiation capacity, and teratoma formation ability.
Conclusions:
- This study reports the first successful generation of de novo gene-expressing HACs in hESc.
- The developed non-integrating system offers a safe and effective method for genetic manipulation of stem cells.
- This breakthrough advances the potential therapeutic applications of stem cells through precise genetic engineering.
Related Concept Videos
Embryonic Stem Cells
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
Embryonic Stem Cells
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.

